How Ozempic created a new marketing opportunity for skin clinics
Inside Retail
SEPTEMBER 13, 2024
Demand for GLP-1 drugs is soaring as Australians turn to the newly approved products, Wegovy and Ozempic, designed to treat diabetes and obesity – but it also has the potential to create a large market for fillers. L’Oréal’s dermatological beauty division has been the company’s leading growth sector since 2019, according to Forbes.
Let's personalize your content